Case Study and Clinical Highlight: Diagnosis of Pulmonary Involvement in Systemic Sclerosis

Case Study and Clinical Highlight: Diagnosis of Pulmonary Involvement in Systemic Sclerosis

Engage in this case study to test your diagnostic ability to differentiate pulmonary hypertension in the setting of systemic sclerosis.

Latest News

Systematic Sclerosis Ulcers Benefit from Hyperbaric Oxygen Treatment

Systematic Sclerosis Ulcers Benefit from Hyperbaric Oxygen Treatment

Hyperbaric oxygen therapy completely healed 4 patient's systemic sclerosis ulcers.

Systemic Sclerosis Linked to Occupational Heavy Metal Exposure

Systemic Sclerosis Linked to Occupational Heavy Metal Exposure

Median levels of 24 elements were assessed in patients with systemic sclerosis and matched controls.

The Handoff: Your Week in Rheumatology News - 2/24/17

The Handoff: Your Week in Rheumatology News - 2/24/17

Juvenile idiopathic arthritis highlights this week's edition, plus other news in the world of rheumatic disease.

Immunosuppressants Effective for Early Diffuse Cutaneous Systemic Sclerosis Treatment

Immunosuppressants Effective for Early Diffuse Cutaneous Systemic Sclerosis Treatment

Prospective, observational study assessed 4 treatment protocols and their effects on skin thickening.

Raynaud Phenomenon: Revisiting a Cold Weather Problem

Raynaud Phenomenon: Revisiting a Cold Weather Problem

A thorough work-up can differentiate between primary and secondary forms, mitigating progression of a more severe underlying disease.

Efficacy of Open-Label Tocilizumab in Early Systemic Sclerosis

Efficacy of Open-Label Tocilizumab in Early Systemic Sclerosis

Dinesh Khanna, MD, MSc, discusses results of the open-label portion of a trial evaluating the safety and efficacy of placebo-treated patients with systemic sclerosis who were switched to received open-label tocilizumab.

Emerging Research in Pediatric Localized Scleroderma

Emerging Research in Pediatric Localized Scleroderma

Sarah Taber, MD, briefly reviews her ongoing research on genetic drivers of localized scleroderma in pediatric patients.

Should the Walk Test Be Used as a Surrogate Marker for CV Hemodynamics in SSc-PAH?

Should the Walk Test Be Used as a Surrogate Marker for CV Hemodynamics in SSc-PAH?

The 6MWD may not accurately serve as a surrogate indicator of treatment outcomes, and that changes in cardiac hemodynamics in response to treatment in patients with SSc-PAH may not be reliably gauged from the 6MWD.

Predictors of Gangrene in Patients With SSc and Digital Ulcers

Predictors of Gangrene in Patients With SSc and Digital Ulcers

Researchers sought to clarify the rates and risk factors of gangrene formation in patients with SSc utilizing the Digital Ulcer Outcomes Registry.

Decreasing Morbidity Associated With Scleroderma By Addressing Pain Management

Decreasing Morbidity Associated With Scleroderma By Addressing Pain Management

As part of Scleroderma Awareness Month, physicians specializing in the management of scleroderma discuss mitigating effects of scleroderma-related pain and improving quality of life for their patients.

Sign Up for Free e-newsletters